CA Patent

CA2049973C — Intralumenal drug eluting prosthesis

Assigned to Medtronic Inc · Expires 2002-12-24 · 23y expired

What this patent protects

A prosthesis for insertion into a lumen to limit restenosis of the lumen. The prosthesis carries restenosis-limiting drugs which elute after the device is positioned in the lumen.

USPTO Abstract

A prosthesis for insertion into a lumen to limit restenosis of the lumen. The prosthesis carries restenosis-limiting drugs which elute after the device is positioned in the lumen.

Drugs covered by this patent

Patent Metadata

Patent number: CA2049973C
Jurisdiction: CA
Classification: —
Expires: 2002-12-24
Drug substance claim: No
Drug product claim: No
Assignee: Medtronic Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.